Nursing Home

Survey, Certification and Operations

We at LeadingAge advocate for a healthy, ethical and affordable oversight system for the nation's nursing homes. We provide updates on regulatory activity issued by the Centers for Medicare and Medicaid Services (CMS) and other federal agencies. Check here often for the latest on regulations, guidance and initiatives, including the CMS Five-Star Nursing Home Rating System, to help you understand compliance requirements.


Featured Content

CMS Announces New Medication Safety Survey and Tool

The Centers for Medicare and Medicaid Services (CMS) has begun pilot testing a focused survey on medication safety systems to look at nursing home practices for high-risk medications, such as Coumadin. CMS has also released a medication-related adverse event tool developed in collaboration with the Agency for Healthcare Research & Quality (AHRQ).

LeadingAge 5-Star Analysis for Nursing Homes

We've added a new tool to our Insights Market Intelligence Suite that will help nursing home members beter understand where to focus efforts to improve resident care and to increase the overall 5-star rating.

Long-Term Care Facility Requirements Updated by CMS Proposed Rule

Undertaking its most comprehensive review and revision since 1991, the Centers for Medicare and Medicaid Services (CMS) has issued a proposed rule updating the Requirements of Participation for nursing homes.

Mandatory Participation in Bundling with Medicare’s Comprehensive Care for Joint Replacement Demonstration

The Centers for Medicare and Medicaid Services (CMS) announced the creation of the Comprehensive Care for Joint Replacement a new demonstration that would make participation in bundled payment for lower extremity joint replacement (LEJR) mandatory in 75 geographic areas across the country.

Beneficiary Disenrollment From Medicare Coverage Without Consent Guidance Issued by CMS

The Centers for Medicare and Medicaid Services (CMS) recently issued guidance to skilled nursing homes and nursing homes after reportedly receiving complaints from beneficiaries and representatives alleging they have been disenrolled from their Medicare advantage prescription drug plans (MAPD) without their consent.